Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer

NCT01487603 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01487603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01487603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2011
Completion date
October 31, 2027
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer